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Abstract
Human milk is a source of biologically active proteins, including lactoferrin (LF) and
antibodies (Abs). These proteins are considered as the most polyfunctional proteins of
human milk. Apparently, human milk is not a simple mixture of proteins and peptides:
recently it was shown that human milk contains stable supramolecular protein com‐
plex, composed of LF, α‐lactalbumin, milk albumin, β‐casein, IgG, and sIgA molecules.
We believe that the whole set of different biological functions of the individual milk
proteins is significantly supplemented by features of their complexes.
Keywords: antibodies, catalytic antibodies, Fab arm exchange, lactoferrin, protein
complexes
1. Introduction
Human milk not only has nutritional value but also is a source of biologically active proteins,
including lactoferrin (LF) and antibodies (Abs). LF and Abs are often considered as the most
polyfunctional proteins of human milk. LF is an iron‐binding glycoprotein and is assumed to
play a key role in iron uptake by the intestinal mucosa; it also keeps iron from iron‐requiring
bacteria acting as a bacteriostatic agent. Major immunoglobulin of human milk is sIgA; besides
that milk contains significant amounts of IgG, along with conventional Abs, human milk contains
anti‐idiotypic Abs capable of enhancing infant antibody response. Maternal milk Abs coat infant
mucosal surfaces, play protective role, and also catalyze various chemical reactions (so‐called
abzymes). Recently it was shown that human milk contains stable supramolecular protein
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complex, which is composed of LF, α‐lactalbumin, milk albumin, β‐casein, IgG, and sIgA
molecules. Here we describe the biological roles of LF and Abs as the major multifunctional
proteins of human milk.
2. Human milk lactoferrin and its known functions
LF is a single polypeptide chain of 76–80 kDa containing two lobes [1] either of which binds
one Fe3+ ion and contains one glycan chain [2]. LF was first isolated and purified from bovine
and human milk [3–5]; then LF was described in human epithelial secretions and barrier body
fluids [6–9]. The concentration of LF in human milk (∼1 mg/ml) is much higher comparing to
cow's milk (up to 0.01 mg/ml) [10]. Considering that LF binds iron [4], it was hypothesized that
LF transports iron in the infant gut. In 1991 the LF receptor specifically binding and trans‐
porting LF was identified on the gut mucosa cells [11, 12]. Since there is no evidence that iron
then enters the bloodstream, it can be concluded that LF does not facilitate iron absorption in
the infant gut [13].
Many different functions have been attributed to LF: immunomodulation and cell growth
regulation [9, 14], protection from iron‐induced lipid peroxidation, DNA binding [9], RNA
hydrolysis [15, 16], and transcriptional activation of specific DNA sequences [17, 18]. LF also
activates natural killer cells [19] and may be effective in antitumor defense, which is not
dependent on iron [14, 20]. It was shown that LF induces granulopoiesis [21], cytotoxicity
mediated by Abs [22], production of cytokines [23], and growth of some cells in vitro [24]. The
role of LF in physiology of these activities is not yet clear, but there are suggestions that LF is
effective for primary defense against viral and microbial infections [6, 8]. The highest concen‐
tration of LF is usually detected in the inflammatory sites since LF is known as a protein of the
acute phase. The blood of newborn babies contains LF during several hours after feeding and
it was shown that LF easily penetrates plasmatic and nuclear membranes of the cells [25].
Protective activity of LF against viral and microbial diseases may increase the newborns’
passive immune system. Since the removal of iron from bacteria eliminates this important
microelement which is ultimately needed for the proliferation of microflora, it was initially
suggested that the antimicrobial properties might be attributed to LF iron‐binding capacity
[26]. Surface receptors for LF are expressed on many microorganisms that may explain
different iron‐independent antimicrobial and antiviral properties of LF [27, 28] in which
mechanisms are still unknown.
It has been proposed that the existence of several oligomeric forms of LF may provide
polyfunctional properties of this relatively small protein. The oligomerization and dissociation
of LF may be under control of specific ligands such as ATP and others [29, 30]. There were
shown some peculiarities of LF molecule ATP‐binding site: interaction of the protein with ATP
leads to changes of LF interaction with DNA, proteins, and polysaccharides [30]. Further it
was demonstrated that LF possesses two DNA‐binding sites which interact with specific and
nonspecific DNAs in an anti‐cooperative manner and may coincide or overlap with the known
polyanion‐binding and antimicrobial domains of the protein [31].
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3. Oligomerization of human milk lactoferrin
It has been reported that at physiological concentrations of NaCl and KCl LF in solution
predominantly exist in two forms—monomeric and tetrameric [19, 32]. However, LF oligo‐
merization has been so far studied by gel filtration using polysaccharide sorbents [19, 32], but
it is known that LF can efficiently interact with polysaccharides [33]. Therefore, LF can bind
to such polysaccharide sorbents and as a result may be eluted only with buffers with high ionic
strength which promote dissociation of LF oligomers [34]. Thus, gel filtration is inadequate for
studying LF and may lead to improper conclusions about the state of LF in solution in the
presence or absence of salts.
The analysis of the LF oligomerization by gel filtration [35] has shown that the LF monomer
and oligomer interactions with resins are remarkably weaker in case of Sepharose 4B. Prior to
gel filtration, the solutions of lyophilized LF (3 mg/ml) were incubated in the absence or in the
presence of different ligands and 0.1–0.15 M KCl for 10 days at 20°C. Gel filtration of LF
preincubated in 50 mM Tris‐HCl pH 7.5 on the Sepharose 4B column resolves the LF sample
into several fractions (Figure 1A, curve 1) demonstrating small reproducible peak at ∼800 kDa
presumably containing LF decamers, major wide peak at ∼310–275 kDa (a tetramer), and small
peaks at ∼150 kDa (a dimer) and at ∼70 kDa (a monomer).
Figure 1. Gel filtration analysis of LF oligomeric forms on Sepharose 4B. Prior to gel filtration, LF was incubated for 20
days at 22°C in 50 mM Tris‐HCl (pH 7.5) in the absence of other ligands (A) or in the presence of 5 mM oligosaccharide
(B), 50 mM ATP (C), or 50 mM AMP (D). The reaction mixtures containing no salt (curve 1), containing 0.1 M (curve 2),
or 0.15 M KCl (curve 3) were used. The column was equilibrated and LF was eluted with the buffer used for the LF
preincubation.
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The addition of 0.1–0.15 M KCl to the buffers leads to the significant decrease of the LF oligomer
forms (Figure 1A, curves 2 and 3). One can suppose that absence of KCl leads to nonspecific
absorbing of dimer and monomer LF forms on the Sepharose 4B resin [35]. Preincubation of
LF in the presence of 0.1 M KCl prior to gel filtration leads to complete dissociation of the
tetramer form (Figure 1B, curve 2) with the most of LF fraction being a dimer. The gel filtration
profile of LF sample incubated with 50 mM ATP in the presence and in the absence of KCl
indicates that such conditions are favorable either for decamer (∼800 kDa) and for tetramer
(∼306 kDa) forms and especially favorable for the dimer and monomer forms of LF (Fig‐
ure 1C). As it can be seen from Figure 1D, 50 mM AMP allows formation of even more stable
complexes: in this condition the most expressed peaks of decamer and tetramer forms are
observed, and again, addition of 0.1 M KCl leads to dissociation of decamer form, but increase
of KCl to 0.15 M stabilizes dimer LF forms. Hereby, oligosaccharide, ATP, and AMP stimulate
the formation of LF oligomers [35].
Denaturing PAGE with 0.1% SDS of the LF preparations preheated with 1% SDS at 100°C
reveals on the gel only one band corresponding to the 80 kDa LF monomer [29–31, 35]. Mild
treatment with 0.1% SDS without heating leads to the detection of oligomeric forms containing
up to six monomers [36]. This leads us to suggestion that LF forms oligomers with a higher
monomer number in solution and that these oligomers are quite stable under mild concentra‐
tions of SDS. The native electrophoresis allowed us to estimate the initial degree of LF
oligomerization and changes of the oligomerization degree due to the presence of various
ligands. The gel after the native electrophoresis revealed several weak bands with different
electrophoretic mobility, including two major bands that could be attributed to the monomer
and the tetramer. After the preincubation with ATP or AMP, most of the proteins remain at
the start of the gel, which leads to suggestion that generation of LF oligomer forms with high
molecular weight is taking place [36]. The results demonstrated that gel filtration and electro‐
phoresis are not the optimal methods for the detection of the LF oligomers existing before and
after binding with different ligands. Therefore, the methods allowing direct detection of
protein oligomer forms in solutions were used: small‐angle X‐ray scattering (SAXS) and light
scattering (LS) [35].
According to the data of 2.8 Å X‐ray analysis and calculations of LF hydration [1], the volume
LF globule is ∼132 Å3. The shape of molecule is close to the ellipsoid and the average radius
of gyration (Rg) and is ∼26.7 Å. The SAXS method allows detecting only small particles, which
are comparable with LF oligomers containing one to four monomers. SAXS spectra from a
standard LF solution (5 mg/ml) were obtained and the average Rg was calculated as 43.7 Å
[35]. LF oligomers dissociate in the presence of 1 M NaCl; therefore the changes in the SAXS
spectra after adding NaCl to LF solution to 1 M final concentration were studied. Values of Rg
after adding NaCl were 38.6 Å after 1 h, 32.9 Å after 20 h, and 27.4 Å after 42 h; during the
further incubation SAXS spectra were stable and the profile matched expected Rg 26.7 Å for
LF monomer. Then the LF solutions were analyzed by the LS method: Rg values estimated for
the solutions of various LF preparations ranged from 450 to 575 Å and depended on the time
of storage and the initial LF concentration. Rg values obtained using LS were one order higher
than obtained by SAXS (43.7 Å). LF oligomers analyzed by LS demonstrated approximately
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the same slow rate of monomer dissociation, and the final values of Rg after long incubation
were similar to SAXS data. Interestingly, lyophilized LF preparations that were solubilized in
a neutral buffer contained substantially lower quantities of oligomer LF: the Rg values for such
solutions were 50–100 Å, which is 5–10 times lower than for the nonlyophilized LF solutions
(450–575 Å). Thereby LF exists in neutral solutions in different oligomer forms, the increase of
LF concentration promotes oligomer formation, but all the oligomers dissociate in the presence
of 1 M NaCl [35].
There may be different possible modes of monomer association into oligomers: a sphere (model
1), a cylinder (model 2), and a plate of the height h and the radius R (model 3) [35]; the estimation
of LF oligomerization type was done taking into account these three different models. The LF
oligomers with Rg 30–44 Å (SAXS) or Rg 50–100 Å (LS) can consist of 8–70, 5–25, or 2–5
monomers depending on the proposed shape of molecule. According to the gel filtration data
(Figure 1), the LF solutions contain at least ∼10‐mer complexes. These results comply with the
model assuming formation of cylindrical structures composed with 10–25 monomers. LS
method has shown that the presence of 0.1 M KCl slows the initial rate of LF oligomerization
in 1.5‐ to twofolds compared to one without salts. The presence of the nucleotides, oligonu‐
cleotides (ODNs), and oligosaccharides increases the Rg values of LF complexes up to 300–
700 Å which corresponds to 5–25 monomers in cylindrical oligomer model. The relatively low
correlation level of Rg values can be explained by conformational changes of LF molecules in
the presence of 1 M KCl due to high conformational lability of LF. According to the SAXS and
LS data, the increase of LF concentration promotes oligomer formation, but all the oligomers
dissociate in the presence of 1 M NaCl.
The effect of d(pT)10 and maltoheptaose on the oligomerization of 3.5 μM LF was analyzed in
detail. In the presence of the oligosaccharide and d(pT)10, Rg was increased from the initial
Rg = 75–100 Å to 304 ± 30 Å and 260 ± 20 Å, respectively [35]. Interestingly, AMP exerted a
greater effect on the efficiency of oligomerization in several LF preparations (Rg = 75–100 Å)
to oligomers demonstrating Rg. = 450–480 Å. Addition of 1 M NaCl to the oligomer complexes
formed in the presence of d(pT)10 and maltoheptaose led to the dissociation into free LF
monomers with Rg 27.3 Å. Remarkably, according to the LS data, the LF decamer can be
formed in all analyzed reaction mixtures and the best ligand‐stimulating decameric complex
formation is AMP and then ATP and the last maltoheptaose. It should be mentioned that each
of the three LF ligands demonstrated two Kd values characterizing the interactions with LF
(see below). Taken together, the results show that interaction of LF with mono‐oligonucleoti‐
des, ODNs, and oligosaccharides can lead to the formation of complexes with various degrees
of oligomerization.
4. Oligonucleotide recognition and catalytic activity of human milk
lactoferrin
It was shown that LF interacts with RNA [15, 16, 37, 38]. Later it was shown that LF can be
considered as sequence‐specific protein, since it interacts with DNA molecules containing
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three specific sequences including specific d(TAGAAGATCAAA) ODN [17, 29, 30, 39]. Later,
it was shown that human milk LF interacts with ATP, NTP, and oligosaccharides [34] and
contains two DNA‐binding sites, interacting with specific and nonspecific ODNs [31].
Detailed analyses of LF interaction with a number of nucleotides, NTPs, NDPs, NMPs, dNTPs,
dNDPs, and dNMPs and their derivatives (e.g., cAMP, cGMP, NAD, ppppA) by fluorescence
analysis have shown that LF contains three nucleotide‐binding sites, which are characterized
by three dissociation constants (Kd). In the case of the first site, the Kd values for various
nucleotides and their derivatives varied from 1.4 × 10-5 M for ADP to 3.6 × 10-7 M for dGDP [40].
Similar results were observed for the second site: the Kd values varied from 3.9 × 10-4 M for
NAD to 7.3 × 10-6 M for cAMP, while the Kd for the third site were in the range from 1.1 × 10-3 
M for NAD to 9.2 × 10-5 M for dCMP [40]. The results obtained by using fluorescence analysis
were confirmed with the measurements of the circular dichroism spectra for LF in the absence
and in the presence of ATP: the Kd for LF‐ATP complex (1.8 × 10-6 M) was comparable with the
fluorescence data (8.3 × 10-6 M). It has been shown that LF binding to the different nucleotides
leads to a change of the intrinsic LF fluorescence indicating that conformation changes in the
protein are caused by LF‐nucleotide complex formation [40].
Using affinity modification of LF by chemically active derivatives of ATP, it was shown that
ATP‐binding site is localized in the C‐terminal domain of LF in contrast to the antibacterial
and polyanion‐binding sites which are located in the N‐terminal domain [30]. In addition, it
was shown that LF has two anti‐cooperative DNA‐binding centers which are localized on the
N‐domain [31]. Interaction of LF with three ATP molecules consists with binding one of the
ATP molecules (high affinity) with a specific ATP‐binding center on C‐terminal domain and
binding of two other ATP molecules (with a lower affinity) with two sites on N‐terminal
domain of LF [41].
It was shown that human milk LF possesses two DNA‐binding sites with different affinity for
specific ODNs: Kd1 ≈ 8 nM (high‐affinity site), while Kd2 ≈ 0.1 mM (low‐affinity site) [31].
Considering the wide range of LF biological functions, it was highly interesting to analyze how
the high‐affinity site of LF recognizes DNA and what are the differences of LF interactions
with DNA comparing to other canonical DNA metabolism enzymes. To evaluate the relative
contributions of individual DNA elements to the enzyme affinity for long DNA, a new
approach, stepwise increase in ligand complexity (or SILC), was developed (reviewed in [42–
44]). Using the SILC approach, many DNA‐dependent enzymes were studied, including those
of not specific for DNA structure or sequence such as E. coli RecA; specific for DNA structure
but not for sequence, such as DNA polymerases of prokaryotes, eukaryotes, viruses, and
human DNA ligase I; specific for DNA damage such as human uracil DNA glycosylase (UDG),
E. coli Fpg and human 8‐oxoguanine DNA glycosylases (OGG1), and human apurinic/
apyrimidinic endonuclease (AP endonuclease); and specific for DNA sequence such as EcoRI
restriction endonuclease, human topoisomerase I (Topo I), and HIV integrase. It was shown
that complex formation, including formation of contacts between all these enzymes and
specific sequences, cannot provide high enzyme affinity for DNA or substrate specificity. All
mentioned enzymes recognize DNA by forming multiple additive contacts with all DNA units
covered by the protein globule (7–20 units depending on the enzyme), and the total interaction
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is a combination of weak electrostatic, hydrophobic, and/or van der Waals interactions of the
enzyme with the individual structural elements of DNA. Thus total interaction can be
described by the following geometric progression:
( ) [ ] n a c g td d i A C G TnK d pN K P e h h h h- - - - -é ù = ´ ´ ´ ´ ´ë û
where Kd[Pi] is the constant of dissociation (Kd) for the orthophosphate (Pi); e is the electrostatic
factor reflecting the interaction with one inter‐nucleoside phosphate group and increase in
enzyme affinity; and h is hydrophobic factor for A, C, G, and T nucleotide bases, corresponding
numbers of which are, respectively, a, c, g, and t. It might be proposed that the interaction of
noncognate single‐stranded (ss) and double‐stranded (ds) DNA with any enzyme can be
described by this equation. The h, Kd, and e values for orthophosphate were reviewed in [42–
44]. The affinity of some DNA‐dependent enzymes to nonspecific d(pN)n does not always
depend on the relative hydrophobicity of the bases. In the case of repair enzymes (8‐oxogua‐
nine DNA glycosylases FPG and OGG1, apurinic/apyrimidinic endonuclease APE) and EcoRI
restriction endonuclease, all hydrophobic factors (a, c, g, and t) were equal to one. These
enzymes interact mainly with internucleotide phosphate groups, and these weak electrostatic
interactions provide high affinity of the d(pN)n for these enzymes (reviewed in [42–44]).
Figure 2. Logarithmic dependencies of LF affinity (Ki = Kd values) for ss and ds; homo‐ and hetero‐ODNs of different
lengths (n) were calculated by LF complexation analysis with ss [32P]sODN1 and its inhibition. Positions of -log(Ki) val‐
ues for ethylated d[(pEt)T)10, d[(pT)(pR)9] (pR is a tetrahydrofuran analog of deoxyribose), specific ss and ds sODN1,
are shown.
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Using the SILC method, the formation of the LF‐DNA complexes with d(pA)1–16, d(pT)1–16,
d(pC)1–16, r(pA)10, r(pU)10, r(pC)10, specific ODN, and several oligodeoxyribonucleotides was
analyzed by electrophoretic mobility shift assay (EMSA) and the Scatchard plot [45]. It was
shown that the interaction of the first high‐affinity LF DNA‐binding site with single‐stranded
(ss) specific and nonspecific ODNs as well as double‐stranded (ds) ODNs is competitive, and
Ki (Kd = Ki) values were estimated [45]. Affinity of LF (Ki) for homo‐ and hetero‐ss and hetero‐
ds ODNs of different lengths (n) is determined by using inhibition of LF complexation with ss
specific for LF [32P]sODN1. It was shown that like all abovementioned DNA‐dependent
enzymes [42–44], the minimal ligands of two LF DNA‐binding sites are mononucleotides and
nucleotide derivatives [45]. The Kd values for minimal ligands of the first LF DNA‐binding site
were calculated: orthophosphate (5 × 10-6 M), deoxyribose phosphate (3 × 10-6 M), and different
dNMPs ((0.56–1.6) × 10-6 M). It means that similarly to other analyzed enzymes [42–44], LF
recognizes free dNMPs through interaction with all structural elements (base, sugar, phos‐
phate), and the phosphate group makes the major contribution to the affinity for dNMPs [45].
Logarithmic analysis of dependencies the Kd for d(pN)n versus the number of mononucleotide
units (n = 1–20) has shown the additivity of free ΔG0 values for the interaction of 10–11
individual nucleotide units of ODNs with LF and the absence of strong cooperative interac‐
tions (Figure 2).
Values of factor f (2.28 ± 0.02), the increase in affinity of LF for various d(pT)n and d(pA)n, were
evaluated from the slopes of the linear parts of these curves (Figure 2). The factor f (2.36 ± 0.03)
for d(pC)n was slightly higher. The values of Kd = 1/f = 0.44 ± 0.004 M for d(pT)n and d(pA)n and
0.42 ± 0.005 M for d(pC)n correspond to the increase of enzyme Kd values. These are reflecting
the interaction between one of ss DNA units and enzyme active center and in turn are equal
to the reciprocals of these factors. The affinity of the first LF‐binding site for dNMPs (0.56–
1.6 mM) is approximately 81–770‐fold higher than for other 9–10 nucleotides (Kd = 0.42–0.44 
M) of an extended ODN [45]. In contrast to DNA polymerases, UDG, AP endonuclease, and
Topo I but similarly to E. coli Fpg, human 8‐oxoG OGG1 glycosylase, and EcoRI endonuclease
[42–44], the affinity of LF for d(pC)n, d(pT)n, and d(pA)n did not depend on the relative
hydrophobicity of their bases (Figure 2). Moreover, LF does not contact 9 of the 10–11 DNA
bases but mainly interacts with the sugar‐phosphate backbone of the ligands. The internu‐
cleoside moieties of ethylated phosphates neutralize their charges and increase the affinity of
d(pT)10 (0.83 μM) up to 12‐fold comparing to ethylated d[p(Et)T]10 (Ki = 10.0 μM) (Figure 2),
indicating that negative charges play an important role in DNA internucleoside phosphate
group interaction with LF. It might be supposed that the lack of all bases except one nucleotide
unit of d(pN)n interacting with LF active center does not influence significantly the LF
interactions with the sugar‐phosphate backbone of ss DNA. Similar to other enzymes [42–44],
the interactions between LF and sugar‐phosphate backbone of DNA may be considered as
weak interactions of oppositely charged surfaces by ion‐dipole and dipole‐dipole interactions.
Most probably, DNA‐ and RNA‐binding sites of LF may be the same or at least significantly
overlap. It was shown that LF binding to polyanions such as heparin and tRNA inhibits the
binding to DNA [31]. Moreover, LF demonstrates higher affinity for r(pA)10 (2.9‐fold),
r(pC)10 (2.8‐fold), and r(pU)10 (7.5‐fold) than that corresponding for d(pN)10. This can be
attributed to extreme biological polyfunctionality of LF, including its ability to activate
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transcription; also it cannot be excluded that r(pN)n can be easier adopted to the first LF nucleic
acids–binding site [45].
It was shown previously that LF interacts specifically with three sequences of ds DNAs and
activates transcription: TAGAAGATCAAA (ODN1), ACTACAGTCTACA (ODN2), and
GGCACTTAC (ODN3) [17]. The affinity of these three ODNs for LF was estimated. It was
shown that ss and ds ODN3 demonstrate the Kd values of 8.0 × 10-7 M and 2.5 × 10-7 M, respec‐
tively. Interestingly, the ss d(pN)9 ((1–3) × 10-6 M)) and ds d(pT)10:d(pA)10 (2.7 × 10-7 M) values
are comparable for those different substrated. It has been proposed that the interaction of LF
DNA‐binding site's central cytosine bases of GGCACTTAC and in the case of different hetero‐
ODNs results in equality of f factor for d(pG)‐mononucleotide units, d(pT)‐ and d(pA)‐links
(f = 2.28; see above). Thereby Kd value for ODN3 was calculated from the equation:
[ ] ( ) ( ) ( )6 2 6 24 7, ,1 1 1 13 5.6 10 7.1 102.28 2.36d d T A G CK ODN K d CMP Mf f - -é ù é ù= é ù × × = × × = ×ë û ê ú ê ×úë ûë û
The calculated Kd value (7.1 ± 0.7) × 10-7 M was comparable with experimental one (8.0 ± 0.7) × 
10-7 M. In a similar way the Kd values for five different nonspecific hetero‐ODNs of different
lengths and sequences were estimated. The experimental Kd values for all five ODNs were also
comparable with the calculated values. The affinity of LF for specific ss ODN2 (Kd = 2.2 × 10-7 
M) was ∼3.9‐fold higher than that for ss d(pT)12–14 or ss d(pA)12–14 (average Kd = (8.6 ± 2.0) × 10-7 
M). Interestingly, these values for ss d(pC)12–14 ((3.0 ± 0.2) × 10-7 M) are 1.4‐fold lower, but ds
ODN2 (Kd = 1.8 × 10-7 M) affinity was approximately twofold lower than that for ds
d(pT)12:d(pA)12 (Kd = 9.0 × 10-8 M), which are completely nonspecific. Specific ss ODN1 (Kd = 8.0 
× 10-8 M; increase in affinity 4.0–7.9‐fold) and ds ODN1 (Kd = 1.0 × 10-8 M; increase in affinity
ninefold) but not others, compared to nonspecific ss (Kd = (3.2–6.3) × 10-7 M) and ds (Kd = 9.0 × 
10-8 M) homo‐d(pN)12 of the same length, demonstrated significantly higher affinity for LF. Of
all hetero‐ODNs only specific ss and ds ODN1 demonstrates significant increase in the affinity
compared to nonspecific ODNs and only this ODN contains TCA trinucleotide. Therefore, one
cannot exclude that this particular trinucleotide sequence may be important for specific
interaction of all nucleotide units of ODN1 with the DNA‐binding site of LF [45]. Similar to all
analyzed enzymes, the second strand contributes to the LF affinity for nonspecific and specific
ds DNA (14–24‐fold; (4–7) × 10-2 M) in a less degree than the first strand ((3–8) × 10-7 M)
(Figure 2) [45].
Interestingly, the relative contributions of specific interactions with specific modified nucleo‐
tide units in the case of UDG, AP endonuclease, and Fpg are comparable on the level of minimal
ligands (dNMP), ss d(pN)n, and ds ODNs [42–44]. This may explain why total affinity for these
repair enzymes is close to additive in case of the specific and nonspecific interactions of specific
DNA with different nucleotides. The cooperative effect on the DNA‐binding groove of the
active site of human OGG1 enzyme may be due to the formation of specific contacts with the
oxoG unit [46]. Some nonspecific, previously weak interactions with noncognate ODNs may
also greatly strengthen when cognate DNA is bound with LF. Since the ratio in the affinity
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(Kd values) for specific and nonspecific ligands significantly increases from mononucleotides
(1.8–2.9 ratio) to ss (4.0–7.9 ratio) and ds ODNs (9.0 ratio), it seems likely that the TCA motif
of ODN1 may be important for possible cooperative interaction of LF DNA‐binding groove
with the specific ds ODN1 [45].
Many data indicate that all enzymes acting on extended DNA molecules first bind to any
sequence of DNA and then slide to the site containing a specific sequence or a lesion (reviewed
in [42–44]). The increase in the affinity (estimated 5 to 790‐fold for different enzymes) for
specific sequence of DNA can change the DNA backbone conformation in multiple ways. The
promotion of the proper fit of specific bases into recognition pockets of the enzymes may be a
result of these bonds formation. Similar mechanism was proposed for specific sequence
searching and DNA recognition by LF. Moreover it was shown that the interaction of LF with
nucleic acids demonstrates some specific features of DNA and RNA recognition compared to
other enzymes studied [45].
5. Five catalytic activities of human milk LF
It was previously shown that human LF possesses protease [47] and RNase [15, 16] activities.
Later the evidence that homogeneous human milk LF possesses five different enzymatic
activities was presented: DNase, RNase, ATPase, phosphatase, and amylase [34]. Several rigid
criteria were applied to show that all hydrolyzing activities are intrinsic properties of LF, rather
than a result of contamination with canonical enzymes. The most important of these criteria
are given below: (a) electrophoretic homogeneity of LF after SDS‐PAGE with silver staining,
(b) adsorption of LF hydrolyzing activities to the anti‐LF Sepharose leading to the disappear‐
ance of catalytic activities from solution and the elution by acidic pH of peak possessing five
catalytic activities, and (c) FPLC gel filtration of LF under conditions of “acidic shock” (pH 2.6)
that does not lead to the disappearance of the activity and to the elution of five in one peak
corresponding to ∼80 kDa LF.
To exclude possible artifacts of contaminating enzymes, modified with affinity reagents, LF
preparations were separated by SDS‐PAGE (Figure 3). It was shown that only LF contains 32P‐
label after its affinity modification with [α‐32P]oxATP (2′,3′‐dialdehyde derivative of ATP), 2′,
3′‐dialdehyde derivatives of [5′‐32P]‐d(pT)9r(pU), and [5′‐32P](pU)10 (Figure 3, lanes 3–5). Two
LF catalytic activities were detected after extraction of proteins from the gel slices (Fig‐
ure 3A, lanes 9 and 10) or were detected in situ using gels containing DNA and RNA (lanes 6
and 7; ethidium bromide staining after 16 h at 37°C revealed dark bands corresponding to LF
molecular mass on a fluorescing background of copolymerized DNA or RNA).
The same results were obtained using in gel ATPase assay in which enzyme‐generated Pi was
precipitated by Pb2+ resulting in Pb2(PO4)3 formation in gel regions containing ATP‐hydrolyz‐
ing molecules (Figure 3, lane 8). Since SDS dissociates any protein complexes, the detection of
five activities in the gel regions corresponding to intact LF molecular mass and the absence of
any other bands of the activity (Figure 3) provide direct evidence that LF possesses five
catalytic activities. It was shown that trypsin at pH 8.2 cleaves the LF molecule between Lys283
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and Ser284 residues resulting in N‐lobe (30 kDa) and C‐lobe (50 kDa) formation [48]. There
were compared DNase and ATPase activities of LF before and after trypsinolysis (Figure 3B).
Interestingly, the high‐affinity DNA (lane 4)‐ and RNA (lane 5)‐binding sites are located on
the N‐fragment (Figure 3B), while ATP‐binding site is located on the C‐fragment (Figure 3B,
lane 6). Overall, our results demonstrate that all five catalytic activities are intrinsic properties
of LF [34].
The above data were obtained using total preparations of LF from different donors. At the
same time, it was shown that LF can be separated by chromatography on Cibacron Blue
Sepharose into many fractions with different affinities for the sorbent [16]. It was analyzed
whether LF fractions exhibiting different affinities for Cibacron Blue Sepharose possess
different catalytic activities [34]. The main subfraction of LF (peak 4, LF‐5, Figure 4) had the
highest affinity for this sorbent, as for three additional subfractions (peaks 1–3, Figure 4) they
represented ∼10–20% of the total LF depending on the milk donor. The first protein peak had
not demonstrated enzymatic activity; at the same time LF fractions corresponding to three
Figure 3. In‐gel detection of enzymatic activities of intact LF and tryptic fragments in 12% SDS‐PAGE gels. (A) Lane 1,
silver stained; lane 2, immunoblotting (alkaline phosphatase‐conjugated anti‐LF antibodies); lanes 3–5, affinity labeling
of LF with periodate‐oxidized [α‐32P]ATP (3), 5′‐[32P](pU)10 (4), or 5′‐[32P]d(pT)9r(pU) (5) (autoradiographs); lanes 6–7
(negatives), DNase and RNase in gels containing calf thymus DNA (6) or yeast RNA (7); lane 8, ATPase activity; lane 9,
phosphatase activity, lane 10, amylolytic activity (RA, relative activity): extracts from 2 to 3 mm gel slices were incubat‐
ed with 5′‐[32P](pT)8 (line 9) or with or with oligosaccharide. (B) Lanes 1 and 2, Coomassie R250‐stained LF (1) and LF
tryptic fragments (2); lanes 3–5, the negatives of the films corresponding to DNase (3, 4), RNase (5), and ATPase (6;
[32P]Pb3(PO4)2 activity of LF (3) and its tryptic fragments (4–6).
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other peaks possessed ODN 5′‐phosphatase, DNase, RNase, ATPase, and maltooligosacchar‐
ide‐hydrolyzing activities, and each activity was eluted in several peaks (Figure 4A–C). LF
subfraction corresponding to the peak 2 possessed four different activities: phosphatase,
DNase, RNase, and ATPase. Eluate corresponding to the protein peak 3 demonstrated three
prominent peaks of ODN 5′‐phosphatase activity (Figure 4B) and two peaks of RNase activity
(Figure 4C). Thus, LF subfractions LF‐1‐LF‐5 (Figure 4) possess different combinations of
various catalytic activities.
The nature of the structural variations that gives rise to these profound functional differences
is not defined. The LF molecule contains two potential glycosylation sites [2], and the degree
of different molecules’ glycosylation varies. LF can contain hexose, mannose, hexoseamines,
or other saccharides [49] and may also differ in level of phosphorylation. Therefore, one cannot
exclude that different affinities of LF fractions to Cibacron Blue Sepharose and specific
distribution of various catalytic activities among these fractions may be due to different types
of LF glycosylation and/or phosphorylation.
DNase activity of human LF differs significantly from other known canonical DNases [34]. The
pH optimum of LF is 7.0–7.5—significantly higher than that (5.0–5.5) of human blood DNase
II. The LF activates significantly (100–150%) by 100 mM NaCl, whereas DNase I is 70%
inhibited by 50 mM NaCl [50, 51]. LF‐mediated cleavage of [32P]‐ODNs and DNA is stimulated
three‐ to fivefold by Ca2+, Cu2+, and Zn2+ and eight to ninefold by Mn2+ or Mg2+ ions. In contrast
to known human DNases, LF DNase activity is activated by ATP, dATP, and NAD (150 mM)
by 1.5–2.5‐fold [34]. Human LF hydrolyzes supercoiled plasmid DNA ∼30–200 times faster
(kcat = 2–9 min-1) than ODNs; the rate is comparable to some DNA restriction endonucleases. It
was shown that in case of RNA hydrolysis LF substrate specificity stands out from RNase A
and other human milk RNases [34]. LF preparations from different donors hydrolyze ATP
with Km ∼3.5 × 10-5 M, and the kcat value ∼2 × 10-3 min-1. As it was shown, maltooligosaccharide
is the best substrate for different LF preparations demonstrating Km ∼ 10-6 M [34].
Taking into account the relative kcat values for LF in the hydrolysis of DNA, RNA, and ATP
and the relative content of LF in human milk comparing to canonical DNases, RNases, and
ATPases, it was shown that the LF is the major DNase, RNase, and ATPase of human milk [34,
41, 52]. Unlike the main LF fraction with the highest affinity for Blue Sepharose, all LF fractions
with DNase activity are cytotoxic and suppress growth of mouse and human tumor cells [52].
The discovery of LF catalytic activities may contribute to understanding of multiple physio‐
logical functions of this extremely polyfunctional protein and explain its protective role against
microbial and viral infections.
6. Catalytic antibodies of human milk
Abs are produced by the plasmatic cells. In traditional view they have a unique function
binding antigens and elicit the immune response. However, it was shown that Abs raised
against chemically stable analogs of the transition states of chemical reaction can possess
different enzymatic activities. These artificial catalytic Abs were termed abzymes (antibody
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enzymes). Abzymes catalyzing more than 100 distinct chemical reactions are reviewed in Refs.
[53–60].
During past two decades, it was shown that the sera of patients with autoimmune diseases
contain auto‐Abs that possess catalytic activities. Now it is obvious that the occurrence of
catalytic Abs is a distinctive feature of AIDs (reviewed in [61, 62]). Naturally occurring
abzymes may be Abs raised directly against enzymes acting as haptens, and mimicking
transition states of catalytic reactions, this process is similar to artificial catalytic Abs raised
against stable analogs of chemical reactions transition states [53–60]. Moreover, the induction
Figure 4. Chromatography of LF on Blue Sepharose and enzymatic activities in five fractions of LF (LF‐1‐LF‐5): (A)
solid line (‐), A280; DNase (•) and ATPase (▲); (B) 5′‐ (∆); (C) RNase (*) and amylase (■). Aliquots (1–3 μl) of chroma‐
tography fractions were used for the determination of DNase (supercoiled DNA), RNase (5′‐[32P](pU)10), phosphatase
(5′‐[32P](pT)8), ATPase (γ‐[32P]ATP), and amylase (4‐nitrophenyl‐4,6‐O‐ethylidene‐α‐D‐maltoheptaose) activities.
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of anti‐idiotypic Abs in AIDs with a primary antigen may result in some antibody catalytic
activities. IgGs and/or IgAs, IgM abzymes hydrolyzing different oligopeptides, proteins, DNA,
RNA, nucleotides, and polysaccharides were detected in the sera of patients with several AIDs.
Healthy humans usually do not develop catalytic Abs or their activities are very low. The
detection of abzymes has been recognized as the earliest indicator of autoimmune process [61,
62].
During pregnancy and immediately after delivery, women are often undergoing immune
system changes similar to that of AIDs (autoimmune diseases) [61–63]. The published data
suggest that pregnant women may be directly immunized through certain compounds of viral,
bacterial, or food origin, which can efficiently stimulate production of different Abs. Immu‐
nization of animals by direct injection of antigens (mainly proteins) into the bloodstream or
by oral administration 1–3 months before delivery leads to the production of Abs against
corresponding proteins which later may be detected in the milk [64]. The generation of human
milk Abs several months after the immunization indicates on the existence of a specific
“immune memory” in lactating and in pregnant women. During the pregnancy, the autoim‐
munization of mothers may be similar to the processes occurring in blood of autoimmune
patients. It has been reported that the level of DNA in the serum of normal women increases
during the first 3 months of pregnancy and this resembles the situation in autoimmune diseases
[65]. In addition, an increased level of apoptosis during the last 3 months of pregnancy has
been demonstrated [66] together with the presence of low numbers of embryonic cells in the
blood of pregnant women [67, 68]. This means that, in contrast to healthy humans, pregnant
women may be efficiently immunized by compounds of various viruses and bacteria.
It was shown that IgGs from the sera of normal 2–7‐month‐old (CBAxC57BL)F1 and BALB/c
mice and from the sera of 2–3‐month‐old autoimmune‐prone MRL‐lpr/lpr mice (conditionally
healthy mice) are catalytically inactive [69–71]. During spontaneous development of deep
system lupus erythematosus like pathology, the specific reorganization of immune system in
these mice leads to the production of IgGs hydrolyzing DNA, ATP, and polysaccharides with
low level of catalytic activity (conditionally prediseased mice). A significant increase in DNase,
ATPase, and amylase activity of IgG is associated with the transition from predisease to deep
disease condition and correlates with additional changes in differentiation and proliferation
of bone marrow hematopoietic stem cells (HSC) and lymphocyte proliferation in different
organs. Abzyme activities in the serum of pregnant females were comparable with those of
predisease mice, but the profile of HSC differentiation and cell apoptosis levels in pregnant
and predisease mice were quite different. Right after the beginning of lactation (4 days after
delivery) and in a late time of lactation (14 days after delivery), the increase in cell apoptosis
and significant changes in two different stages of the HSC differentiation profiles were
observed; the first stage was accompanied with a significant increase and the second with a
remarkable decrease in abzyme activity [69–71]. These data indicate that women blood and
milk can contain various Abs against foreign and self‐antigens (including abzymes) in high
concentrations.
sIgAs and IgGs possessing DNase, RNase, amylase, and ATPase activities were found in blood
serum and milk of pregnant and lactating females [63, 72–77]. It was shown that milk of
Milk Proteins - From Structure to Biological Properties and Health Aspects64
clinically healthy human mothers contains quite unusual sIgA and IgGs possessing protein
[78–80], lipid [81–83], and polysaccharide kinase activities [84–86]. The most impressive
catalytic activities of human milk Abs are synthesizing ones (kinase activities), which are not
detected for any serum antibody under any autoimmune disease. It was shown that IgGs and
sIgAs phosphorylate not only casein but also approximately 15 other milk proteins [78–80]. It
was shown that milk sIgA and IgG contain tightly bound lipids and oligosaccharides of
unusual structure and these Abs effectively phosphorylate these ligands [81–85]. In contrast
to canonical kinases, milk abzymes can transfer phosphate group to proteins, lipids, and
oligosaccharides not only from ATP but also from all NTPs and dNTPs; the most surprising
is that inorganic orthophosphate is also very good substrate [78–85]. Canonical enzymes using
orthophosphate as a donor of phosphate groups are not yet found.
Many autoimmune pathologies can be “activated” or “triggered” in clinically healthy women
during pregnancy and soon after childbirth [87, 88]. Independent of detectable autoimmune
reactions during pregnancy woman may sometimes develop postnatal autoimmune patholo‐
gies such as system lupus erythematosus, Hashimoto's thyroiditis, phospholipid syndrome,
polymyositis, and autoimmune myocarditis. One of the most frequently found postnatal
autoimmune pathologies is Hashimoto's thyroiditis (1.9–16.7%) [88–90]. Various manifesta‐
tions of these AIDs can be detected during the first 3–6 postnatal months. Interestingly, the
relative activity of human blood Abs significantly increases after delivery and in the beginning
of lactation. Moreover, catalytic activity of human milk Abs is 5–600‐fold higher comparing
the sera of the same women [63, 77]. Interestingly, the antibody DNase activity in blood of
healthy pregnant women was four‐ to fivefold lower than that of pregnant women with
pronounced autoimmune thyroiditis [63]. Thus, one cannot exclude that molecular mecha‐
nisms of immune system activation which leads to production of autoreactive or autoanti‐
bodies with and without catalytic activity are, to some extent, similar or overlapping in both
autoimmune patients and human mothers.
Overall, pregnancy and especially the beginning of lactation may be considered as important
periods associated with the production not only of different Abs against foreign antigens, auto‐
Abs, but also of Abs hydrolyzing foreign and self‐antigens. Many abzymes from sera of
autoimmune patients and sera and milk of human mothers possess the same activities
including hydrolysis of DNA, RNA, nucleotides, and proteins. At the same time, they can have
different biological functions. For example, DNase abzymes from sera of system lupus
erythematosus [91], multiple sclerosis [92], and DNA‐hydrolyzing Bence‐Jones proteins from
multiple myeloma patients [93] are cytotoxic, cause nuclear DNA fragmentation, and induce
cell death by apoptosis, at the same time, DNase abzymes from human milk are not cytotoxic.
Antiviral and antibacterial defenses of gut mucosal membranes are among the most important
functions of human milk Abs. Immune exclusion may be achieved by entrapping viruses in
immune complexes and its transcytosis and excretion into the lumen by inhibiting pathogens
adherence to mucosal surface and by agglutination of microorganisms or interference with
bacterial flagella [94]. According to our data, in contract to destructive abzymes of autoimmune
patients, abzymes of human milk have a clear protective role against different harmful antigens
and different infections [95, 96].
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7. Fab arm exchange of human milk antibodies
Abs usually considered as the products of clonal B cell populations each producing Abs which
recognize a single antigen. There is a common belief that mammalian biological fluids contain
monovalent IgG molecules with two identical antigen‐binding sites and stable structures. The
Fab arm exchange of Abs was first described for isotype 4 of immunoglobulin G (IgG4) [97–
100]. As the result of posttranslational modification, IgG4 molecule exchange with half
molecules (HL fragments) becomes bispecific and provides anti‐inflammatory activity.
Mutagenesis studies revealed that for this activity CH3‐domain is critical, and the in vitro
experiments have shown that adding 0.1–10 mM of reduced glutathione (GSH) is sufficient to
induce Fab arm exchange of IgG4 [98]. Later it was shown that natalizumab and other
monoclonal Abs also exchange by Fab arms in vivo with endogenous human IgG4 in treated
individuals that makes IgG4 unsuitable for human immunotherapy [101].
Polyspecificity may be defined as binding of Ab molecule to a large panel of diverse antigens.
It was shown that the large number of monoclonal Abs can bind to the variety of totally
unrelated foreign and self‐antigens. Therefore, it was proposed that the best explanation of
Abs polyreactivity is the flexibility of the antigen‐binding “pocket” which can change confor‐
mation and accommodate different unrelated antigens [102]. There is no doubt that due to
change of the conformation, some monoclonal Abs can bind not only specific antigen with
high affinity but also some cognate and even foreign compounds with lower affinity. It is
known that canonical enzymes can sometimes interact nonspecifically with foreign ligands
demonstrating lower affinity comparing to specific substrates, but they usually cannot catalyze
conversion of molecules of noncognate compounds. For example, it was shown that affinity
of many sequence‐specific enzymes for specific and nonspecific DNAs differs more often
∼tenfold and rarely up to 100‐fold. However, these enzymes catalyze the conversion of only
specific DNAs [43].
Human milk IgGs and sIgAs were separated by affinity chromatography on DNA cellulose
[103, 104]. The fractions of Abs with different affinity for DNA were analyzed in the hydrolysis
of DNA, ATP, and oligosaccharides as well as in phosphorylation of proteins, lipids, and
oligosaccharides. It was surprising that all IgG and sIgA fractions including those eluted under
the conditions destroying strong complexes of antigen‐binding sites with specific antigens (3 
M NaCl, 2 M MgCl2) have not only efficiently hydrolyzed DNA but also ATP and oligosac‐
charides as well as phosphorylated casein, oligosaccharides, and lipids. The same preparations
of IgGs and sIgAs were separated on ATP‐Sepharose, casein‐Sepharose, and lipid‐saturated
silica gel; in all cases all antibody catalytic activities were distributed all over the profiles of all
chromatograms (Figure 5).
These results cannot be explained with the current concept of one type of two (IgGs) or more
(sIgAs) identical antigen‐binding site of Abs. Using this concept, it was impossible even to
explain the high affinity of several fractions of Abs for several different affinity sorbents and
moreover the catalytic polyreactivity of different fractions. But the presence of two different
antigen‐binding sites in one IgG or up to four sites in one sIgA molecule can easily explain the
nature of binding polyspecificity and catalytic polyreactivity. Our data indicated that human
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milk contains not only monofunctional catalytic Abs but also hybrid bifunctional IgGs and
polyfunctional sIgAs with different combinations of HL fragments possessing distinct
affinities and catalytic activities [103, 104].
To establish in vivo Abs Fab arm exchange in human milk, IgGs and sIgAs were separated by
affinity chromatography on anti‐κ‐L‐Sepharose and anti‐λ‐L‐Sepharose bearing immobilized
monoclonal Abs to human κ‐ and λ‐light chains. The IgG fraction having affinity for anti‐κ‐L‐
Sepharose was re‐chromatographed on anti‐λ‐L‐Sepharose and vice versa. The relative
percentage of Abs having affinity only for anti‐κ‐L‐Sepharose, only to anti‐λ‐L‐Sepharose, and
to both of these sorbents was evaluated. In addition, using ELISA it was confirmed that IgGs
having affinity only for anti‐λ‐L‐Sepharose do not contain κ‐IgGs, while IgGs with affinity for
anti‐κ‐L‐Sepharose are free of λ‐IgGs. But IgGs interacting with both affinity sorbents demon‐
strated positive response to mouse Abs against human λ‐ and κ‐Abs [103]. Similar results were
obtained in the case of milk sIgAs [104]. It was shown that milk IgG preparations contain ∼33%
Figure 5. Affinity chromatography of human milk polyclonal IgGs on DNA cellulose (A), ATP‐Sepharose (B), casein‐
Sepharose (C), and lipid‐resin (D): (—), absorbance at 280 nm; symbols correspond to the relative catalytic activities
(RA) in the hydrolysis of DNA (∆), ATP (฀), and oligosaccharides (×); phosphorylation of lipids (■) and polysacchar‐
ides (฀) tightly bound to IgGs (A and B), hydrolysis of DNA (∆), ATP (฀), and phosphorylation of casein (฀) and lipids
tightly bound with Abs (■) (C and D). Depending on the RA and reaction analyzed, the reaction mixtures were incu‐
bated for 0.5–2 h and then the RAs were normalized to the standard conditions and the RA of the fraction with the
highest activity was taken for 100%. The average error in the initial rate determination from two experiments in each
case did not exceed 7–10%.
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of Abs only with κ‐light chains, ∼13% only with λ‐chains, and ∼54% of IgGs with both κ‐
and λ‐light chains simultaneously proving the bispecific nature of milk IgG molecules. Nearly
the same results were obtained in case of sIgA: ∼48% of Abs contained only κ‐light chains,
∼35% contained only λ‐chains, and ∼17% were presented by chimeric molecules simultane‐
ously containing both types of the light chains [104]. Significantly lower quantity of bispecif‐
ic sIgAs comparing to IgGs can appear due to secretory component and/or J‐chain which may
hinder the exchange of sIgA by HL fragments. It is well known that B‐lymphocytes or plasmatic
cells producing Abs express only one gene coding light chain—of κ‐ or λ‐type—as the other
copies of light chain genes are removed during cell maturation. The exceptions to this rule are
described in transformed hybridoma, leukemia, and myeloma cells and appear as the result
of abnormalities; they are not observed in human milk donors [105, 106].
It was shown that chimeric bispecific human milk IgGs are presented mostly by IgG1 (74%)
and lower amounts of IgG2–IgG4 (5–16%). Our data provided the evidence that in milk not
only IgG4 but all IgG subclasses and also sIgA molecules can exchange with HL fragments,
but not with individual light or heavy chains [103, 104].
The experiments on monoclonal IgG4 have shown that exchange with Fab arms in vitro occurs
in the presence of reduced glutathione [99, 101]. The exchange of HL fragments between IgG
and between sIgA molecules in vitro was studied using FITC and 32P‐labeled Abs. Nonla‐
beled and labeled IgG and sIgA fractions with different affinities for DNA were eluted from
DNA cellulose with gradient of NaCl (0–3 M) and 8 M urea (initial chromatography). First, in
control experiments the fractions of 32P/FITC‐labeled and 32P/FITC‐unlabeled Abs exhibiting
lower and higher affinities for DNA were mixed in the presence of only reduced glutathione
(GSH) or only milk plasma, incubated for 24 h, and subjected to re‐chromatography on DNA
cellulose (e.g., Figure 6). The radioactive (fluorescent) label was eluted with the same
concentrations of salt (or urea) as in the case of the initial chromatography indicating the
impossibility of the HL fragment exchange in these conditions (Figure 6B and C).
But in experiments when mixtures of 0.6 M [32P]IgGs and 0.15 M IgGs were incubated in the
presence of both GSH and milk plasma after re‐chromatography on DNA cellulose, the
radioactive label was mainly distributed between three peaks. The main part of the total 32P‐
label moved to two IgG peaks with low affinity, and one corresponded to the initially
nonradioactive IgGs 0.15 M IgGs (e.g., Figure 6A). Reverse situation was observed in the case
of 0.15 M [32P]IgGs and 0.6 M IgGs: as the result of Fab arm exchange, the most of 32P label was
detected in the IgG peaks and eluted with high NaCl concentration (≥0.6 M). Similar results
were obtained in the case of IgGs labeled with FITC. Overall, after the exchange, 25–60% of
labeled IgGs changed the affinity for DNA cellulose [103]. In the case of sIgA HL fragments,
exchange led to the transition of only 11–20% of Ab from one fraction to another [104]. This is
consistent with a lower content of chimeric κλ‐sIgAs in human milk, and it may be due to
hampering of the exchange with HL fragments by secretory and J‐components of sIgA.
Thus, it has been shown that human milk contains unknown factor(s) stimulating the IgG and
sIgA Fab arms exchange in the presence of reduced glutathione. Since the intact human milk
contains GSH and other reducing compounds in significant concentrations, HL‐fragment
exchange can occur in vivo directly in human milk [103, 104]. In addition, it cannot be excluded
Milk Proteins - From Structure to Biological Properties and Health Aspects68
that during the penetration of IgAs through the specific milk barrier, the secretory compo‐
nent (S) and the joint chain (J) can combine molecules of dimeric H2L2 λλ‐IgAs, κκ‐IgAs, and
chimeric κλ‐IgAs against different antigens forming many different variants of (HL)4SJ sIgA
molecules. Therefore, some chimeric molecules of sIgAs can in principle contain from two up
to four HL fragments to various antigens interacting with high affinity for different sorbents
and catalyzing various chemical reactions.
It was shown recently that similarly to human milk Abs placenta, Abs undergo to extensive
half‐molecule exchange and IgG pools in average consist of ∼43.5% κκ‐IgGs and 41.6% of λλ‐
IgGs, while 15.0% of the IgGs contained both κ‐ and λ‐light chains [107]. κκ‐IgGs and λλ‐IgGs
contained, respectively, IgG1 (47.7% and 34.4%), IgG2 (36.3% and 44.5%), IgG3 (7.4% and
11.8%), and IgG4 (7.5% and 9.1%), while chimeric κλ‐IgGs consisted of 43.5% IgG1, 41.0% IgG2,
5.6% IgG3, and 7.9% IgG4. The relative content of chimeric IgGs (∼15.0%) in placenta is
significantly lower than that of the milk (up to 54%). It can be supposed that the observed
Figure 6. Affinity chromatography of nonmodified and 32P‐labeled polyclonal IgGs on DNA cellulose: (‐‐‐) and (—),
absorbance of IgGs at 280 nm before and after phosphorylation using γ‐[32P]ATP, respectively; the bars correspond to
the relative radioactivity (RR) of [32P]IgG fractions (A–C). Analysis of a relative efficiency of half‐molecule exchange
under different conditions between nonmodified IgGs and [32P]IgGs having different affinity for DNA cellulose (A–C).
Before chromatography the IgG preparations eluted from DNA cellulose by 0.15 M NaCl (0.15 M IgGs) were incubated
with [32P]IgGs eluted by 0.6 M NaCl (0.6 M [32P]IgG) in the presence of GSH and milk plasma containing no Abs (A) or
in the presence of only GSH (B) or only milk plasma containing no Abs (C).
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phenomenon may appear due to a lower content of factor(s) stimulating the exchange in
placenta comparing with milk.
8. Complexes of human milk, containing antibodies and lactoferrin:
structure, stability, and potential functions
Since the most biological processes are performed by protein complexes and many compo‐
nents of human milk are multifunctional and cooperate with other factors to produce specific
effects modulating growth and development of neonates [108], identification and characteri‐
zation of human milk protein complexes are important for understanding sophisticated
functions of human milk. The complexes of LF with other proteins may be the most widely
represented in human milk due to LF polyfunctionality and ability to form oligomers, as it was
described above.
It was shown that LF interacts with calmodulin, a ubiquitous 17‐kDa regulatory calcium‐
binding protein localized in the cytoplasm and nucleus of activated cells [109], with casein
micelles [110], with β‐lactoglobulin and albumin [111], and with ceruloplasmin [112]. All these
complexes are relatively unstable.
Different methods to analyze whether in human milk LF can form any very stable protein
complexes with other milk proteins were used [113]. Using gel filtration of milk proteins on
Sepharose 4B column, there was a purified stable high molecular mass (∼1000 kDa) multipro‐
tein complex (SPC) from 15 preparations of human milk (Figure 7A and 7B). By the LS and
gel filtration, the stability of SPC was shown in the presence of high concentrations of NaCl
and MgCl2; however, the SPC efficiently dissociated in 2 M MgCl2, 0.5 M NaCl, and 10 mM
dithiothreitol—the conditions of immune complex dissociation (Figure 7C).
Obviously, it is unlikely that such stable complex is an occasional protein association. The
amount of SPCs in total milk protein content varied from 6 to 25%. With electrophoretic
analysis and MALDI TOF MS data, it was shown that all 15 SPCs contained LF and α‐
lactalbumin as major proteins, while human milk albumin and β‐casein were present in
moderate or minor amounts; a different content of IgGs and sIgAs depending on milk samples
was observed. In addition, this complex contains several proteins/peptides with relatively low
molecular masses (3–9 kDa) which have not yet been identified. All SPCs efficiently hydro‐
lyzed DNA and maltoheptaose. Some fresh SPC preparations contained not only intact LF but
also small amounts of its fragments which appeared in all SPCs during their prolonged storage.
The fragments similarly to intact LF possessed DNase and amylase activities. It may be a
consequence of a presence in SPCs of any canonical proteases in very low amounts or
manifestations of the proteolytic activity directly by LF.
As it was mentioned above, oligomers of electrophoretic homogeneous LF completely
dissociate during the gel filtration in the presence of NaCl [35]. However, human milk SPCs
contain several other proteins and are very stable, requiring high concentrations of MgCl2,
NaCl, and DTT for effective dissociation [113]. These data suggest that large and small proteins
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in the SPCs are mainly interacting by electrostatic forces. At the same time, SPCs can be
partially destroyed in the presence of 8 M urea which basically breaks the hydrogen bonds.
Since DTTs increase the SPC dissociation, the binding of some proteins with disulfide bonds
should be considered important for high stability of the SPCs. The presence of stable supra‐
molecular complex in human milk exhibiting DNA and oligosaccharide hydrolyzing activity
can be another reason for the extreme diversity of the human milk biological functions. Taking
into consideration the LF functions listed above, complexes of LF with other milk proteins may
be important for LF in vivo activity.
9. Conclusion
Obviously, human milk proteome is not a simple mixture of proteins and peptides. Milk
proteins interact with each other, form supramolecular complexes, and catalyze various
Figure 7. Isolation and analysis of milk protein complex stability. Gel filtration of untreated human milk (1 ml) of first
donor (profile 1) and its plasma after removal of fat‐lipid fraction (profile 2) on a Sepharose 4B column: (__) and (‐‐‐),
absorbance at 280 nm (A280) corresponding to milk and plasma, respectively (A). Concentrated milk plasma (1 ml) of
two donors was gel filtrated: (‐‐‐) and (__); absorbance at 280 nm (A280) corresponds to different donors (B). Changes of
the relative LS intensity were measured in the equimolar mixture of SPCs from 15 milk samples (0.5 mg/ml) under dif‐
ferent conditions (C); all conditions are shown in panel C. The highest relative LS at zero time of the incubation was
taken for 100% (C).
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processes—hydrolytic, synthetic, and exchange reactions. The biological roles of milk proteins
and protein complexes are very diverse: milk proteins may hydrolyze foreign (viral, bacteri‐
al) DNA and oligosaccharides of antigenic epitopes, and dietary milk proteins (casein) may
increase the diversity of antigen‐binding sites combinations in one molecule and regulate and
enhance infant immune response. Some new binding sites for different ligands and catalytic
centers with new enzymatic functions may be formed at interfaces of the LF molecules with
other proteins, as well as in contact zones of different proteins incorporated to the possible
supramolecular protein structures. We believe that the whole set of different biological
functions of the individual milk proteins and their various complexes, extremely unusual
abzymes with hydrolytic and synthetic function, as well as complexes of proteins, Abs, and
abzymes with nucleic acids, lipids, and oligosaccharides, are still very poorly studied.
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